Latest updates
Hearing health news, audiology research, FDA updates, and industry developments — curated for consumers and professionals.
New AI-powered hearing aid technology is helping people with hearing loss focus on speech and tune out background noise — and researchers say better hearing engagement may slow cognitive decline.
Meta is rolling out a software feature for its Ray-Ban smart glasses that amplifies and clarifies speech in real time — positioning a $329 consumer device as a hearing accessibility tool for the first time.
Sam’s Club selected NationsBenefits to manage its hearing centers nationwide, adding a hybrid model for consultations, fittings, and remote support.
No direct company or regulatory record was verified for the claimed corporate events. This draft remains unavailable to search indexing while editorial review is completed.
No direct company or regulatory record was verified for the claimed shutdown or customer implications. This draft remains unavailable to search indexing while editorial review is completed.
Unsubstantiated trend and performance claims have been removed. This draft remains unavailable to search indexing while editorial review is completed.
The unsupported 2026 follow-up, 48% figure, and outcome claims have been removed. This draft remains unavailable to search indexing while editorial review is completed.
All unverified event details and service counts have been removed. This draft remains unavailable to search indexing while editorial review is completed.
Claims about 2026 warning letters, companies, violations, and future plans have been removed. This draft remains unavailable to search indexing while editorial review is completed.
Specific manufacturer, performance, and pricing claims have been removed pending primary evidence. This draft remains unavailable to search indexing while editorial review is completed.
The claimed trial phase, result, mechanism, and regulatory status have been removed. This draft remains unavailable to search indexing while editorial review is completed.
State-law counts, benefit amounts, and federal-policy assertions have been removed pending direct legislative sources. This draft remains unavailable to search indexing while editorial review is completed.
The unverified 2026 update and related numerical claims have been removed. This draft remains unavailable to search indexing while editorial review is completed.
No official company announcement was verified for the claimed expansion or OTC shelf program. This draft remains unavailable to search indexing while editorial review is completed.
The unverified teen prevalence analysis and demographic figures have been removed. This draft remains unavailable to search indexing while editorial review is completed.